How to Switch to HeMed from Another Weight Loss Programme

Switching weight loss programmes is more common than most people realise. Your current provider might have run into supply problems, the clinical support might feel inadequate, or you might simply want a programme built with men in mind. Whatever has brought you here, moving between providers while staying on medication requires a bit of planning.

This guide covers what to think about before you switch, how the HeMed process works, and what to expect during the transition.

‍

Why Men Switch Weight Loss Programmes

Most men who switch do so for one of a handful of reasons.

Supply and continuity issues. 

Medication availability across UK providers has been patchy since demand for GLP-1 treatments increased sharply. Gaps in treatment can affect both progress and tolerability when you restart, so a provider that can reliably source your medication matters more than it might seem.

Lack of clinical oversight. 

Some programmes hand you a prescription and leave you to get on with it. If nobody is monitoring your blood markers, adjusting your dose, or checking in on side effects, you are essentially managing a prescription medication on your own. That is not how these treatments are designed to work.

A need for male-specific support. 

Most weight loss platforms are built around a general or female-skewed audience. Men have different risk profiles, different motivations, and different patterns of weight-related health issues. A programme that accounts for those differences tends to feel more relevant and, in practice, be more useful.

Cost or convenience. 

Home delivery, app-based tracking, and streamlined clinical reviews can make a real difference to whether someone actually stays on a programme long enough to see results.

What to Do Before You Switch

Do not stop your medication abruptly without clinical advice

If you are currently on a GLP-1 medication such as semaglutide or tirzepatide, stopping suddenly is not recommended without speaking to a clinician first. Dosing schedules matter, and your new provider will need to know where you are in your titration before continuing your treatment safely.

Contact your current provider and ask for a summary of your treatment history: the medication you are on, your current dose, and how long you have been at that dose.

Gather your recent health information

Your new clinical team will carry out their own assessment, but having a record of relevant health information to hand speeds things up, including any side effects you have experienced during treatment.

Check eligibility before assuming you can transfer directly

Switching programmes does not mean automatic continuation. Every regulated provider in the UK is required to carry out their own eligibility assessment before prescribing. This is not a bureaucratic inconvenience -- it is how safe prescribing works.

‍

How the HeMed Switch Process Works

HeMed is a medical weight loss programme for men in the UK that combines prescription medication with clinical oversight, blood testing, and app-based progress tracking. Whether you are starting fresh or switching from another provider, the process follows the same structured steps.

‍

Step 1: Online eligibility check

You complete a detailed online questionnaire covering your health history, current medications, BMI, and weight loss goals. HeMed's clinical team reviews this - it is not a rubber stamp. They use the information to determine whether treatment is appropriate and, if so, which medication and starting dose makes sense given your history.

‍

If you are already on a GLP-1 treatment, you can indicate this during the assessment. The clinical team will factor in your current dose and how long you have been on treatment when making their recommendation.

‍

Step 2: At-home blood test

Before treatment begins, HeMed requires an at-home blood test. It is a no-needle tasso+ blood collection test that you complete at home and return by post, measuring ten health biomarkers including HbA1c, cholesterol, and liver function markers.

‍

This step matters for several reasons. It gives the clinical team a baseline picture of your metabolic health, can identify issues that would affect how your treatment is managed, and means you are not simply handed a prescription without anyone knowing what is actually going on with your health. If you have had blood tests recently through your current provider, the HeMed team may take those into account, but the at-home test remains part of the standard process.

‍

Step 3: Prescription and discreet delivery

Once your eligibility is confirmed and your blood results reviewed, your medication is dispensed and delivered to your home in discreet packaging. HeMed offers Wegovy (semaglutide injection), the Wegovy Pill, and Mounjaro (tirzepatide). The clinical team will recommend the most appropriate option based on your assessment.

‍

For more detail on what these medications involve, the Wegovy guide on the HeMed blog covers dosage, side effects, and efficacy. If you are considering Mounjaro, the Mounjaro for men page explains how it works and what to expect.

‍

Step 4: Ongoing clinical support and monitoring

This is where HeMed differs from many providers. The clinical team monitors your progress throughout treatment, adjusts your dose as needed, and continues tracking your ten health biomarkers at regular intervals. You follow your progress through the HeMed app, which keeps everything in one place.

‍

Dose adjustments are not automatic. They are based on how you are responding to treatment, how well you are tolerating the medication, and what your health data shows. That kind of active oversight is what separates a genuine clinical programme from a prescription delivery service.

‍

What to Expect During the Transition

There may be a short gap between programmes

Depending on how quickly you complete the eligibility check and blood test, there may be a brief period between your last dose with your current provider and your first with HeMed. This is normal and manageable, but worth planning for. If you are concerned about timing, raise it with HeMed's clinical team during your assessment -- they can advise based on where you are in your titration.

‍

Your dose may be adjusted

If you have been on a higher dose with your previous provider, the clinical team will review whether continuing at that level is appropriate given your assessment and blood results. In some cases, a short adjustment period may be recommended to ensure tolerability. That is not a setback - it is responsible prescribing.

‍

Side effects may shift slightly

Even when switching between providers offering the same medication, small differences in formulation, delivery method, or timing can affect how your body responds. Keep a note of any changes in how you feel during the first few weeks and report them through the HeMed app or directly to the clinical team.

‍

When Switching Might Not Be the Right Move

Switching programmes is not always the answer. If you are experiencing significant side effects, have had a change in your health status, or are unsure whether medication is still the right approach, the right first step is a conversation with your GP.

Weight loss medication is one tool. It works best alongside changes to diet, activity, and sleep. If those foundations are not in place, a new provider will not change the underlying picture.

HeMed's clinical team will be straightforward with you about whether treatment is appropriate. If the assessment suggests it is not the right time, that is the correct outcome -- not a failure of the process.

‍

A Note on Switching Medications, Not Just Providers

Some men switch providers because they want to try a different medication. Moving from semaglutide to tirzepatide, or the other way around, is a clinical conversation rather than a self-directed choice. The HeMed assessment accounts for this - the team will consider your history, your current health markers, and the available evidence before recommending a specific treatment.

‍

Frequently Asked Questions

Can I switch to HeMed if I am already on Mounjaro or Wegovy through another provider? Yes. HeMed accepts men who are currently on GLP-1 medication through another provider. You will still need to complete the eligibility check and at-home blood test before treatment begins. The clinical team will review your current dose and treatment history as part of the assessment.

Will I have to restart at the lowest dose if I switch to HeMed? 

Not necessarily. The clinical team will review where you are in your titration and make a recommendation based on your individual circumstances. In some cases, continuing at or near your current dose is appropriate. In others, a short adjustment period may be advised.

How long does the switch process take? 

The online eligibility check takes around ten to fifteen minutes. Once you return your blood test, results are typically available within a few days. The full process from starting your assessment to receiving your first delivery can take one to two weeks, depending on how quickly you complete each step.

What if I have had side effects with my current medication? 

Disclose any side effects during the eligibility questionnaire. The clinical team will take this into account when deciding whether to continue with the same medication, adjust the dose, or recommend an alternative.

Do I need a letter or referral from my current provider to switch?

No referral is required. HeMed carries out its own independent assessment. Having a record of your current dose and treatment duration is helpful, but it is not a prerequisite.

Is there a gap in medication supply when switching? 

There may be a short gap depending on timing. If that concerns you, raise it during your assessment. The clinical team can advise on how to manage the transition based on your current schedule.

What happens to my ongoing monitoring if I switch mid-treatment? 

HeMed's clinical team will establish a new baseline using your blood test results and assessment data. Monitoring of your ten health biomarkers continues throughout your treatment with HeMed, regardless of what monitoring you had with your previous provider.

Ready to Make the Switch?

If your current programme is falling short on clinical support, medication continuity, or male-specific focus, the switch to HeMed is a straightforward process. The programme is built around what men actually need: proper oversight, regular health monitoring, and a clinical team that adjusts your care as you progress.

‍

Start with the HeMed eligibility check and find out whether HeMed is the right fit for you.

‍